Page last updated: 2024-08-16

sb 239063 and glutamine

sb 239063 has been researched along with glutamine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agusti, A; Cauli, O; Felipo, V; Hernández-Rabaza, V; Llansola, M; Rodrigo, R	1
Lu, GM; Su, YY; Wu, S; Yang, GF; Zhang, LJ	1

Reviews

1 review(s) available for sb 239063 and glutamine

Article	Year
PET and MR imaging of neuroinflammation in hepatic encephalopathy. Metabolic brain disease, 2015, Volume: 30, Issue:1 Topics: Amino Acid Transport System X-AG; Animals; Blood-Brain Barrier; Brain; Brain Edema; Cytokines; Disease Models, Animal; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Hyperammonemia; Imidazoles; Inflammation; Isoquinolines; Magnetic Resonance Imaging; Microglia; Mitochondria; Multimodal Imaging; Neuroimaging; Portacaval Shunt, Surgical; Positron-Emission Tomography; Psychometrics; Pyrazoles; Pyrimidines; Rats	2015

Article

Year

PET and MR imaging of neuroinflammation in hepatic encephalopathy.

Metabolic brain disease, 2015, Volume: 30, Issue:1

Topics: Amino Acid Transport System X-AG; Animals; Blood-Brain Barrier; Brain; Brain Edema; Cytokines; Disease Models, Animal; Glutamate-Ammonia Ligase; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Hyperammonemia; Imidazoles; Inflammation; Isoquinolines; Magnetic Resonance Imaging; Microglia; Mitochondria; Multimodal Imaging; Neuroimaging; Portacaval Shunt, Surgical; Positron-Emission Tomography; Psychometrics; Pyrazoles; Pyrimidines; Rats

2015

Other Studies

1 other study(ies) available for sb 239063 and glutamine

Article	Year
p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut, 2011, Volume: 60, Issue:11 Topics: Ammonia; Animals; Blotting, Western; Cerebellum; Cerebral Cortex; Cognition; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Imidazoles; Immunohistochemistry; Learning; Male; MAP Kinase Signaling System; Microglia; Motor Activity; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Portacaval Shunt, Surgical; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Rats; Rats, Wistar	2011

Article

Year

p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.

Gut, 2011, Volume: 60, Issue:11

Topics: Ammonia; Animals; Blotting, Western; Cerebellum; Cerebral Cortex; Cognition; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Imidazoles; Immunohistochemistry; Learning; Male; MAP Kinase Signaling System; Microglia; Motor Activity; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Portacaval Shunt, Surgical; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Rats; Rats, Wistar

2011